Orphazyme A/S Profit Margin

Orphazyme A/S's profit margin stands at -485.57% as of June 2026. That is below the Healthcare sector average of 19.13%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Orphazyme A/S sits lower the Healthcare benchmark (19.13%) with a profit margin of -485.57%. That is roughly 2638.1% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A profit margin of -485.57% for Orphazyme A/S means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how Orphazyme A/S's profit margin evolved across reporting periods, while the comparison chart places ORPH next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, profit margin is commonly used to spot outliers. Orphazyme A/S's reading of -485.57% (sector avg 19.13%) is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.